收藏切换
Progress in the clinical application of all-trans-retinoic acid in solid tumors
收藏切换
Cong RUAN1, Jiajia QIAN1, Qiong DU1, 2, 3, Qing ZHAI1, 2, 3, Xiaomin SUN4, Rui XU1, *
World Clinical Drug | 2024, 45(7) : 697 - 702
Less
收藏切换
World Clinical Drug | 2024, 45(7): 697-702
• Topic •
Progress in the clinical application of all-trans-retinoic acid in solid tumors
Full
Cong RUAN1, Jiajia QIAN1, Qiong DU1, 2, 3, Qing ZHAI1, 2, 3, Xiaomin SUN4, Rui XU1, *
Affiliations
  • 1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China
  • 2.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China
  • 3.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  • 4.Shandong LONGFINE Pharmaceutical Co., Ltd., Jining 272600, Shandong Province China
Published: 2024-07-10 doi: 10.13683/j.wph.2024.07.001
Outline
收藏切换

All-trans-retinoic acid (ATRA) is the clinical choice for the treatment of acute promyelocytic leukemia. However, in recent years, a large number of studies have shown that ATRA maintains the human normal immune microenvironment by inhibiting the immune escape effect of tumor stem cells and promoting the differentiation of myeloid-derived suppressor cells, and enhances the efficacy of chemotherapeutic drugs, targeted drugs and immunotherapy drugs in solid tumors. This paper reviewed the clinical trial progress of ATRA in solid tumors to provide a reference for its further clinical application.

all-trans-retinoic acid  /  solid tumor  /  tumor stem cells  /  myeloid-derived suppressor cells  /  immunomodulation
阮聪, 钱佳佳, 杜琼, 翟青, 孙晓敏, 徐蕊. 全反式维甲酸在实体瘤中临床应用进展. 世界临床药物, 2024 , 45 (7) : 697 -702 . DOI: 10.13683/j.wph.2024.07.001
Cong RUAN, Jiajia QIAN, Qiong DU, Qing ZHAI, Xiaomin SUN, Rui XU. Progress in the clinical application of all-trans-retinoic acid in solid tumors[J]. World Clinical Drug, 2024 , 45 (7) : 697 -702 . DOI: 10.13683/j.wph.2024.07.001
Year 2024 volume 45 Issue 7
19
6
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2024.07.001
  • Receive Date:2023-07-23
  • Online Date:2026-11-17
  • Published:2024-07-10
Article Data
Affiliations
History
  • Received:2023-07-23
  • Revised:2023-08-08
Funding
Affiliations
    1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China
    2.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China
    3.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
    4.Shandong LONGFINE Pharmaceutical Co., Ltd., Jining 272600, Shandong Province China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.07.001
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT